Literature DB >> 22992562

Necrotizing pneumonia caused by Panton-Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus (MSSA).

Vincenzo Catena1, Marco Baiocchi, Paolo Lentini, Luigi Badolati, Monica Baccarin, Daniele D Del Monte, Alessandro Rubini.   

Abstract

Staphylococcus aureus harboured by Panton-Valentine leukocidin (PVL) is emerging as a serious problem worldwide. There has been an increase in the incidence of necrotizing lung infections in otherwise healthy young people with very high mortality rate associated with these strains. This report documents a confirmed case of necrotizing pneumonia due to methicillin-susceptible S. aureus (MSSA) harbouring Panton-Valentine leukocidin genes. An apparently healthy 49-year old man was admitted to our hospital for dyspnea and he quickly developed acute respiratory distress syndrome. MSSA harbouring Panton-Valentine leukocidin genes were cultured from the abscess fluid and from multiple blood specimens. Aggressive antibiotic therapy was started and intensive supportive care led finally to a complete recovery. Rapid identification of Panton-Valentine leukocidin in MSSA samples should be supposed when a young, immunocompetent patient, develops a necrotizing pneumonia. Bactericidal antistaphylococcal antibiotics are recommended for the treatment as soon as possible to avoid the potentially devastating consequences of this kind of S. aureus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992562

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  2 in total

1.  Staphylococcus aureus bacteremic pneumonia.

Authors:  C De la Calle; L Morata; N Cobos-Trigueros; J A Martinez; C Cardozo; J Mensa; A Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-15       Impact factor: 3.267

2.  Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.

Authors:  Charles Emeka Okolie; Alan Cockayne; Christopher Penfold; Richard James
Journal:  BMC Biotechnol       Date:  2013-11-19       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.